vs
GERMAN AMERICAN BANCORP, INC.（GABC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
GERMAN AMERICAN BANCORP, INC.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.7倍（$126.7M vs $75.5M），GERMAN AMERICAN BANCORP, INC.同比增速更快（39.7% vs 27.7%），GERMAN AMERICAN BANCORP, INC.自由现金流更多（$154.0M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 22.7%）
German American Bancorp, Inc.（股票代码：GABC）是一家美国的银行控股企业，专注于提供多元金融服务，核心业务涵盖支付卡相关服务，总部位于纽约曼哈顿下城的巴特利公园城，在金融服务领域拥有成熟的业务布局。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
GABC vs PBYI — 直观对比
营收规模更大
GABC
是对方的1.7倍
$75.5M
营收增速更快
GABC
高出12.0%
27.7%
自由现金流更多
GABC
多$139.6M
$14.4M
两年增速更快
PBYI
近两年复合增速
22.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $126.7M | $75.5M |
| 净利润 | $35.7M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 34.6% | 22.7% |
| 净利率 | 28.2% | — |
| 营收同比 | 39.7% | 27.7% |
| 净利润同比 | 53.7% | — |
| 每股收益（稀释后） | $0.98 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GABCPBYI
| Q4 25 | $126.7M | $75.5M | ||
| Q3 25 | $126.5M | $54.5M | ||
| Q2 25 | $123.2M | $52.4M | ||
| Q1 25 | $111.1M | $46.0M | ||
| Q4 24 | $90.7M | $59.1M | ||
| Q3 24 | $88.5M | $80.5M | ||
| Q2 24 | $90.5M | $47.1M | ||
| Q1 24 | $84.1M | $43.8M |
净利润GABCPBYI
| Q4 25 | $35.7M | — | ||
| Q3 25 | $35.1M | $8.8M | ||
| Q2 25 | $31.4M | $5.9M | ||
| Q1 25 | $10.5M | $3.0M | ||
| Q4 24 | $23.2M | — | ||
| Q3 24 | $21.0M | $20.3M | ||
| Q2 24 | $20.5M | $-4.5M | ||
| Q1 24 | $19.0M | $-4.8M |
毛利率GABCPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率GABCPBYI
| Q4 25 | 34.6% | 22.7% | ||
| Q3 25 | 34.6% | 17.6% | ||
| Q2 25 | 31.8% | 12.7% | ||
| Q1 25 | 12.0% | 8.7% | ||
| Q4 24 | 31.6% | 22.6% | ||
| Q3 24 | 29.0% | 27.4% | ||
| Q2 24 | 29.4% | -4.6% | ||
| Q1 24 | 27.6% | -5.3% |
净利率GABCPBYI
| Q4 25 | 28.2% | — | ||
| Q3 25 | 27.7% | 16.2% | ||
| Q2 25 | 25.5% | 11.2% | ||
| Q1 25 | 9.5% | 6.5% | ||
| Q4 24 | 25.6% | — | ||
| Q3 24 | 23.8% | 25.2% | ||
| Q2 24 | 22.7% | -9.6% | ||
| Q1 24 | 22.6% | -11.0% |
每股收益（稀释后）GABCPBYI
| Q4 25 | $0.98 | $0.26 | ||
| Q3 25 | $0.94 | $0.17 | ||
| Q2 25 | $0.84 | $0.12 | ||
| Q1 25 | $0.30 | $0.06 | ||
| Q4 24 | $0.79 | $0.40 | ||
| Q3 24 | $0.71 | $0.41 | ||
| Q2 24 | $0.69 | $-0.09 | ||
| Q1 24 | $0.64 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $100.0M | $22.7M |
| 股东权益账面价值 | $1.2B | $130.3M |
| 总资产 | $8.4B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.09× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资GABCPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务GABCPBYI
| Q4 25 | $100.0M | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $114.6M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益GABCPBYI
| Q4 25 | $1.2B | $130.3M | ||
| Q3 25 | $1.1B | $115.3M | ||
| Q2 25 | $1.1B | $104.7M | ||
| Q1 25 | $1.0B | $97.1M | ||
| Q4 24 | $715.1M | $92.1M | ||
| Q3 24 | $744.6M | $71.1M | ||
| Q2 24 | $687.8M | $48.5M | ||
| Q1 24 | $655.3M | $51.0M |
总资产GABCPBYI
| Q4 25 | $8.4B | $216.3M | ||
| Q3 25 | $8.4B | $202.9M | ||
| Q2 25 | $8.3B | $194.9M | ||
| Q1 25 | $8.4B | $196.2M | ||
| Q4 24 | $6.3B | $213.3M | ||
| Q3 24 | $6.3B | $220.7M | ||
| Q2 24 | $6.2B | $205.0M | ||
| Q1 24 | $6.1B | $214.1M |
负债/权益比GABCPBYI
| Q4 25 | 0.09× | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 0.16× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $159.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $154.0M | $14.4M |
| 自由现金流率自由现金流/营收 | 121.6% | 19.1% |
| 资本支出强度资本支出/营收 | 4.2% | 0.0% |
| 现金转化率经营现金流/净利润 | 4.46× | — |
| 过去12个月自由现金流最近4个季度 | $267.0M | $41.7M |
8季度趋势，按日历期对齐
经营现金流GABCPBYI
| Q4 25 | $159.3M | $14.4M | ||
| Q3 25 | $51.8M | $9.7M | ||
| Q2 25 | $26.9M | $14.1M | ||
| Q1 25 | $37.9M | $3.6M | ||
| Q4 24 | $95.8M | $15.6M | ||
| Q3 24 | $24.5M | $11.0M | ||
| Q2 24 | $18.7M | $1.0M | ||
| Q1 24 | $23.9M | $11.2M |
自由现金流GABCPBYI
| Q4 25 | $154.0M | $14.4M | ||
| Q3 25 | $50.1M | $9.7M | ||
| Q2 25 | $26.2M | $14.1M | ||
| Q1 25 | $36.7M | $3.6M | ||
| Q4 24 | $90.7M | $15.6M | ||
| Q3 24 | $23.0M | $11.0M | ||
| Q2 24 | $17.0M | $1.0M | ||
| Q1 24 | $22.6M | — |
自由现金流率GABCPBYI
| Q4 25 | 121.6% | 19.1% | ||
| Q3 25 | 39.6% | 17.7% | ||
| Q2 25 | 21.2% | 26.8% | ||
| Q1 25 | 33.0% | 7.7% | ||
| Q4 24 | 100.1% | 26.4% | ||
| Q3 24 | 26.0% | 13.7% | ||
| Q2 24 | 18.8% | 2.1% | ||
| Q1 24 | 26.9% | — |
资本支出强度GABCPBYI
| Q4 25 | 4.2% | 0.0% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 1.1% | 0.1% | ||
| Q4 24 | 5.6% | 0.0% | ||
| Q3 24 | 1.7% | 0.0% | ||
| Q2 24 | 1.8% | 0.0% | ||
| Q1 24 | 1.5% | 0.0% |
现金转化率GABCPBYI
| Q4 25 | 4.46× | — | ||
| Q3 25 | 1.48× | 1.10× | ||
| Q2 25 | 0.86× | 2.41× | ||
| Q1 25 | 3.61× | 1.21× | ||
| Q4 24 | 4.13× | — | ||
| Q3 24 | 1.16× | 0.54× | ||
| Q2 24 | 0.91× | — | ||
| Q1 24 | 1.25× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
